Radiology Personnel

Hubert Vesselle, Ph.D., M.D.

Nuclear Medicine
Contact Me


Dr. Vesselle is a UW professor of Radiology, UW Division of Nuclear Medicine. He specializes in evaluating complex cancer cases with PET/CT and SPECT/CT scanners. In addition to devoting himself to the application of these hybrid scanners to cancer and non-cancer patients, he also practices general nuclear medicine and cross-sectional imaging (CT). His research aims at applying and improving hybrid imaging to better characterize diseases and their response to treatments.

Dr. Vesselle trained as an engineer in France and then moved to the United States to earn a Ph.D. in biomedical engineering and then his M.D. degree from Case Western Reserve University in Cleveland. He pursued his graduate medical education in diagnostic radiology and nuclear radiology at University Hospitals of Cleveland and the Cleveland Clinic. In 1997, he came to the UW to join the faculty of the Department of Radiology. Since 2006, he has been the director of the UW Division of Nuclear Medicine in the Department of Radiology.

He is listed in “”The Best Doctors in America”” and in “”Seattle Met Top Doctors””. He is board-certified in diagnostic radiology with special competence in nuclear radiology.

Awards and Honors

Recent Publications (via Semantic Scholar)

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer
S. Bowen, D. Hippe, H. Thomas, et al. - Published 2021 - MEDRXIV

Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
K. Horn, H. Thomas, H. Vesselle, et al. - Published 2021 - CLINICAL NUCLEAR MEDICINE

A Phase I Trial of First-in-Human Alpha-Emitter Astatine-211-Labeled Anti-CD45 Antibody (211At-BC8-B10) in Combination with Fludarabine and TBI As Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome
B. Sandmaier, D. Wilbur, D. Hamlin, et al. - Published 2021

Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
M. Ishiyama, F. Behnia, H. Vesselle - Published 2021 - AJR. AMERICAN JOURNAL OF ROENTGENOLOGY

Concordance of quantitative FDG PET/CT imaging biomarkers for classifying early response to chemoradiotherapy in patients with locally advanced non-small cell lung cancer.
K. Horn, Hannah Tomas, H. Vesselle, et al. - Published 2020

COVID-19 in an asymptomatic patient undergoing FDG PET/CT
Lisa N. Johnson, H. Vesselle - Published 2020 - RADIOLOGY CASE REPORTS

Predicting Survival in Patients Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Using Mid-Treatment Imaging Response and Radiation Parameters
J. Zeng, H. Thomas, R. Rengan, et al. - Published 2020

Abstract 6497: Early assessment of liquid biomarkers to predict pneumonitis after chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC)
J. Zeng, R. Rengan, R. Santana-Davila, et al. - Published 2020

Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Chunyan Duan, W. Chaovalitwongse, F. Bai, et al. - Published 2020 - PHYSICS IN MEDICINE AND BIOLOGY

High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma *
T. Akaike, J. Qazi, A. Anderson, et al. - Published 2020 - THE BRITISH JOURNAL OF DERMATOLOGY